Inhaled corticosteroids may have a protective effect against coronavirus infection
- PMID: 33528938
- DOI: 10.15586/aei.v49i1.40
Inhaled corticosteroids may have a protective effect against coronavirus infection
Abstract
Background: Spain has been severely affected by the COVID-19 epidemic, with 195,944 persons infected and 20,453 deaths at the time of writing. Older people with respiratory or cardiac conditions are most at risk.
Objective: The aim was to compare respiratory symptoms in nursing home residents and patients with uncontrolled asthma, who are considered vulnerable to COVID-19.
Methods: We studied 134 nursing home residents and 139 patients with uncontrolled asthma, groups vulnerable to COVID-19. Demographic characteristics, clinical manifestations, outcomes, key laboratory results, and radiological images were collected from medical records. COVID-19 infection was detected by polymerase chain reaction (PCR).
Results: Thirteen (9.3%) patients with uncontrolled asthma, all receiving inhaled corticosteroids were infected by COVID-19. Eighty (60%) nursing home residents were infected; only 28, all of whom had received inhaled corticosteroids, had a good prognosis.
Conclusions: Early treatment with inhaled corticosteroids may be helpful in COVID-19 infection. Persons with an allergy might have some protective mechanisms against coronavirus.
Keywords: COVID; Th2 cell immunity; allergy; asthma severe; coronavirus; coronavirus infection; corticosteroids; nursing home; telemedicine.
Conflict of interest statement
The authors report no conflicts of interest.
References
-
- 1. World Health Organization Coronavirus disease 2019 (COVID-19) Situation Report. Available from: https://www.who.int/docs/default-source/coronaviruse/20200312-sitrep-52-....
-
- 2. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. 10.1001/jama.2020.2648 - DOI
-
- 3. Korean Society of Infectious Diseases. Report on the epidemiological features of coronavirus disease 2019 (COVID-10) outbreak in the Republic of Korea from January 19 to March 2, 2020. J Korean Med Sci. 2020;35(10):e112. 10.3346/jkms.2020.35.e112 - DOI
-
- 4. Shaker MS, Oppenheimer J, Grayson M, Stukus D, Hartog N, Hsieh E, et al. COVID-19: pandemic contingency planning for the Allergy and Immunology Clinic. J Allergy Clin Immunol Pract. 2020;8:1477.e5–1488.e5. 10.1016/j.jaip.2020.03.012 - DOI
-
- 5. Jiang X, Hou X, Tang L, Jiang Y, Ma G, Li Y. A phase trial of the oral Lactobacillus casei vaccine polarizes Th2 cell immunity against transmissible gastroenteritis coronavirus infection. App Microbiol Biotechnol. 2016;100:7457–7469. 10.1007/s00253-016-7424-9 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical